28062126|t|Cross reactivity of immune responses to porcine reproductive and respiratory syndrome virus infection
28062126|a|Because porcine reproductive and respiratory syndrome virus (PRRSV) exhibits extensive genetic variation among field isolates, characterizing the extent of cross reactivity of immune responses, and most importantly cell-mediated immunity (CMI), could help in the development of broadly cross-protective vaccines. We infected 12 PRRSV -naïve pigs with PRRSV strain FL12 and determined the number of interferon (IFN)-γ secreting cells (SC) by ELISpot assay using ten type 2 and one type 1 PRRSV isolates as recall antigens. The number of IFN-γ SC was extremely variable among animals, and with exceptions, late to appear. Cross reactivity of IFN-γ SC among type 2 isolates was broad, and we found no evidence of an association between increased genetic distance among isolates and the intensity of the CMI response. Comparable to IFN-γ SC, total antibodies evaluated by indirect immunofluorescence assay (IFA) were cross reactive, however, neutralizing antibody titers could only be detected against the strain used for infection. Finally, we observed a moderate association between homologous IFN-γ SC and neutralizing antibodies.
28062126	0	16	Cross reactivity	T044	C0872139
28062126	20	36	immune responses	T042	C0301872
28062126	40	91	porcine reproductive and respiratory syndrome virus	T005	C0376536
28062126	92	101	infection	T046	C3714514
28062126	110	161	porcine reproductive and respiratory syndrome virus	T005	C0376536
28062126	163	168	PRRSV	T005	C0376536
28062126	179	188	extensive	T080	C0205231
28062126	189	206	genetic variation	T070	C0042333
28062126	219	227	isolates	T123	C1764827
28062126	248	254	extent	T082	C0439792
28062126	258	274	cross reactivity	T044	C0872139
28062126	278	294	immune responses	T042	C0301872
28062126	317	339	cell-mediated immunity	T043	C3536823
28062126	341	344	CMI	T043	C3536823
28062126	365	376	development	T169	C1527148
28062126	388	404	cross-protective	T033	C1545588
28062126	405	413	vaccines	T121,T129	C0042210
28062126	418	426	infected	T033	C0439663
28062126	430	435	PRRSV	T005	C0376536
28062126	443	447	pigs	T015	C0039005
28062126	453	470	PRRSV strain FL12	T005	C0376536
28062126	475	485	determined	T080	C0521095
28062126	500	518	interferon (IFN)-γ	T116,T121,T129	C0021745
28062126	519	534	secreting cells	T025	C0007634
28062126	536	538	SC	T025	C0007634
28062126	543	556	ELISpot assay	T059	C0677645
28062126	567	594	type 2 and one type 1 PRRSV	T005	C0376536
28062126	595	603	isolates	T123	C1764827
28062126	607	622	recall antigens	T033	C1855779
28062126	638	643	IFN-γ	T116,T121,T129	C0021745
28062126	644	646	SC	T025	C0007634
28062126	651	660	extremely	T080	C0205403
28062126	661	669	variable	T080	C0439828
28062126	676	683	animals	T008	C0003062
28062126	722	738	Cross reactivity	T044	C0872139
28062126	742	747	IFN-γ	T116,T121,T129	C0021745
28062126	748	750	SC	T025	C0007634
28062126	757	763	type 2	T005	C0376536
28062126	764	772	isolates	T123	C1764827
28062126	800	808	evidence	T078	C3887511
28062126	845	852	genetic	T169	C0314603
28062126	853	861	distance	T081	C0012751
28062126	868	876	isolates	T123	C1764827
28062126	902	914	CMI response	T043	C3536823
28062126	930	935	IFN-γ	T116,T121,T129	C0021745
28062126	936	938	SC	T025	C0007634
28062126	946	956	antibodies	T116,T129	C0003241
28062126	970	1003	indirect immunofluorescence assay	T059	C0282647
28062126	1005	1008	IFA	T059	C0282647
28062126	1015	1029	cross reactive	T044	C0010357
28062126	1040	1061	neutralizing antibody	T116,T129	C0475463
28062126	1062	1068	titers	T081	C0475208
28062126	1083	1091	detected	T033	C0442726
28062126	1104	1110	strain	T080	C0456178
28062126	1120	1129	infection	T046	C3714514
28062126	1194	1199	IFN-γ	T116,T121,T129	C0021745
28062126	1200	1202	SC	T025	C0007634
28062126	1207	1230	neutralizing antibodies	T116,T129	C0475463